Amit Khurana - Concepedia

Author

Amit Khurana

National Institute of Pharmaceutical Education and Research ORCID

Also Known As

Amit Khurana, Amit khurana, Khurana, Amit

113

Publications

4.9K

Citations

H-Index

105

Concepts

All Affiliations

National Institute of Pharmaceutical Education and Research P.V. Narsimha Rao Telangana Veterinary University National Institute of Pharmaceutical Education and Research Indian Institute of Technology Delhi Indian Institute of Technology Roorkee

About

Amit Khurana is an author at National Institute of Pharmaceutical Education and Research specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	1.5K
2	Engineering	5	5	244
3	Biochemistry	3	3	159
4	Health Sciences	1	1	92
5	Natural Sciences	1	1	12

Amit Khurana

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Role of nanotechnology behind the success of mRNA vaccines for COVID-19 Amit Khurana, Prince Allawadhi, Isha Khurana, Nano Today VaccinationNanomedicineCross-protectionVaccine DevelopmentVaccine Target	2021	265
Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy Goru Santosh Kumar, Apoorva Kulkarni, Amit Khurana, Chemico-Biological Interactions Type 1UrologyRenal FunctionSelenium DeficiencyMedicine	2014	147
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics Vishakha Singh, Amit Khurana, Umashanker Navik, Sci ApoptosisImmunologyCell DeathPathologyHomeostatic Balance	2022	92
Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation Swetha Sangomla, Mohd Aslam Saifi, Amit Khurana, Journal of Trace Elements in Medicine and Biology InflammationNanomedicineInduced CardiotoxicityEngineeringAnti-inflammatory	2018	91
Silver nanoparticle based multifunctional approach for combating COVID-19 Prince Allawadhi, Vishakha Singh, Amit Khurana, Sensors International	2021	86
Nanoceria as a possible agent for the management of COVID-19 Prince Allawadhi, Amit Khurana, Sachin Allwadhi, Nano Today Long CovidCovid-19 PandemicVirologyPossible AgentMedicine	2020	82
Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes Sravani Tekula, Amit Khurana, Pratibha Anchi, Biomedicine & Pharmacotherapy InflammationMetabolic SyndromeDiabetes ManagementMedicineDiabetes	2018	80
Visnagin attenuates acute pancreatitis via Nrf2/NFκB pathway and abrogates associated multiple organ dysfunction Lakshmi Priya Pasari, Amit Khurana, Pratibha Anchi, Biomedicine & Pharmacotherapy	2019	74
Nanoceria Suppresses Multiple Low Doses of Streptozotocin-Induced Type 1 Diabetes by Inhibition of Nrf2/NF-κB Pathway and Reduction of Apoptosis Amit Khurana, Sravani Tekula, Chandraiah Godugu Nanomedicine	2018	71
Protective Effect of Nanoceria on Cisplatin-Induced Nephrotoxicity by Amelioration of Oxidative Stress and Pro-inflammatory Mechanisms Mohd Aslam Saifi, Swetha Sangomla, Amit Khurana, Biological Trace Element Research InflammationNanomedicineBiochemistryMedicineLipid Peroxidation	2018	69

Page 1